Mankind Pharma launches 'Limit White India' campaign to raise hypertension awareness

FDA approves Merck’s WINREVAIR for treatment of pulmonary arterial hypertension

WINREVAIR is a breakthrough biologic for this rare, progressive disease

Innovent and SanegeneBio collaborate to develop siRNA drug for treatment of hypertension

Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908

Unichem receives ANDA approval for hypertension drug

Nebivolol is used alone or together with other medicines to treat high blood pressure

Alembic receives USFDA tentative approval for hypertension drug

Macitentan tablets, 10 mg have an estimated market size of US $ 797 million for twelve months ending Dec 2021 according to IQVIA

Experts say extended day prescription refills for hypertension can be a game-changer

The recently released WHO guideline on hypertension treatment (2021), recommends that patients with stable blood pressure can be asked to visit clinics at 3-6 month intervals as an important strategy to improve hypertension control

Nearly half of cardiac investigations in men above 30 show abnormalities, claims report

Study of 78,000 diagnostic investigations by Mahajan Imaging identifies over 13,000 abnormal or critical findings, highlighting silent health risks among working-age men

Lupin secures 180-day exclusivity for generic Azilsartan Medoxomil tablets in U.S. market

Company introduces bioequivalent version of Edarbi for hypertension treatment following U.S. FDA approval; product recorded annual U.S. sales of USD 53.5 million

Smile Foundation delivers 20 lakh healthcare treatments in FY26

Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006

CARE Hospitals strengthens advanced cardiac care

The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries